
A Medicine Company | Eli Lilly and Company
Lilly is a medicine company that puts health above all. Learn about our medicines, view condition support, find care, and much more.
Eli Lilly and Company - Wikipedia
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries.
Lilly Cares Application | Lilly Cares
Access the online and mail-in applications for the Lilly Cares Foundation to receive free Lilly medications for eligible patients.
Eli Lilly and Company (LLY) - Yahoo Finance
Find the latest Eli Lilly and Company (LLY) stock quote, history, news and other vital information to help you with your stock trading and investing.
Eli Lilly’s obesity drug retatrutide clears late-stage ... - CNBC
3 days ago · Lilly is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound and its upcoming pill, orforglipron.
Eli Lilly’s road to Pennsylvania, details of new $3.5B plant ...
5 days ago · Eli Lilly’s road to Pennsylvania, details of new $3.5B plant, celebrated in the Lehigh Valley
Amid US investment push, Lilly eyes Houston as potential home for …
May 19, 2025 · With $27 billion earmarked to expand its U.S. production footprint starting this year, Eli Lilly is busy scouting out potential sites for new drug ingredients plants.
Eli Lilly looks to bring $5.9 billion facility to Houston - InnovationMap
May 21, 2025 · Pharmaceutical company Eli Lilly and Company is looking to build a $5.9 billion active pharmaceutical ingredient (API) manufacturing facility in Houston, according to a recent filing with the …
Lilly to expand pharmaceutical manufacturing with four new sites
Feb 27, 2025 · Eli Lilly has announced plans to expand its domestic medicine production in the US by establishing four new pharmaceutical manufacturing sites. The move increases the company’s total …
Lilly's triple agonist, retatrutide, demonstrated significant ...
3 days ago · Lilly is studying retatrutide in several Phase 3 clinical trials to evaluate its potential efficacy and safety in obesity and overweight with at least one weight-related medical problem, type 2 ...